Related Experiment Video

Updated: Jul 16, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

Current guidelines for treatment of heart failure: 2006 update

Nabil Uddin1, J Herbert Patterson

  • 1Division of Pharmacotherapy, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

Pharmacotherapy
|March 27, 2007
PubMed

Insights

Updated heart failure guidelines now strongly recommend beta-blockers and angiotensin II receptor blockers, incorporating aldosterone antagonists. Pharmacists need to understand these evidence-based treatment strategy changes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Practice Guidelines

Background:

  • Recent clinical trials have significantly advanced the understanding of drug therapy for heart failure.
  • Existing treatment guidelines required updates to reflect new evidence.

Purpose of the Study:

  • To review pivotal clinical trials in heart failure drug therapy.
  • To summarize the updated Heart Failure Society of America (HFSA) and American College of Cardiology-American Heart Association (ACC-AHA) guidelines.
  • To inform pharmacists about evolving heart failure treatment strategies.

Main Methods:

  • Review of evidence from key clinical trials.
  • Analysis of updated HFSA (2006) and ACC-AHA (2005) guidelines.
  • Synthesis of guideline changes and supporting trial data.

Main Results:

  • New guidelines feature broader, stronger recommendations for beta-blocker therapy.
  • Strong recommendations are now included for angiotensin II receptor blockers.
  • Aldosterone antagonists (spironolactone, eplerenone) are incorporated into the updated guidelines.

Conclusions:

  • The updated guidelines reflect significant advancements in heart failure pharmacotherapy.
  • Pharmacists require familiarity with these changes to optimize patient care.
  • These updates represent an evolving understanding of effective heart failure treatment strategies.

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...